AC Immune SA
ACIUNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for ACIU. That does not mean none is planned.
Get an email about ACIU's next catalysts
Track AC Immune (ACIU) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 1 past
No catalysts found.
Market Overview
Stock performance and key metrics
ACI-35.030
Alzheimer's Disease
ACI-24.060 at Dose A
Amyloid Plaque
ACI-7104.056 at Dose A
Parkinson Disease
ACI-24.060 with an additional adjuvant at Dose E in Study Part 1b
Amyloid Plaque
JACI-35.054
Alzheimer's Disease
ACI-7104.056 at Dose B (optional)
Parkinson Disease
ACI-24.060 with an additional adjuvant at Dose D in Study Part 1b
Amyloid Plaque
ACI-24.060 at Dose A in Study Part 1a
Amyloid Plaque
ACI-7104.056 at Dose C (optional)
Parkinson Disease
ACI-24.060 at Dose B in Study Part 1a
Amyloid Plaque
ACI-24.060 at Dose C in Study Part 1a
Amyloid Plaque
ACI-24.060 at Dose A in Study Part 2
Amyloid Plaque
ACI-24.060 at Dose B in Study Part 2
Amyloid Plaque
ACI-24.060 at Dose C in Study Part 2
Amyloid Plaque
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
ACI-35.030 | Phase 2 | Alzheimer's Disease | - | - |
ACI-24.060 at Dose A | Phase 2 | Amyloid Plaque | - | - |
ACI-7104.056 at Dose A | Phase 2 | Parkinson Disease | - | - |
ACI-24.060 with an additional adjuvant at Dose E in Study Part 1b | Phase 2 | Amyloid Plaque | - | - |
JACI-35.054 | Phase 2 | Alzheimer's Disease | - | - |
ACI-7104.056 at Dose B (optional) | Phase 2 | Parkinson Disease | - | - |
ACI-24.060 with an additional adjuvant at Dose D in Study Part 1b | Phase 2 | Amyloid Plaque | - | - |
ACI-24.060 at Dose A in Study Part 1a | Phase 2 | Amyloid Plaque | - | - |
ACI-7104.056 at Dose C (optional) | Phase 2 | Parkinson Disease | - | - |
ACI-24.060 at Dose B in Study Part 1a | Phase 2 | Amyloid Plaque | - | - |
ACI-24.060 at Dose C in Study Part 1a | Phase 2 | Amyloid Plaque | - | - |
ACI-24.060 at Dose A in Study Part 2 | Phase 2 | Amyloid Plaque | - | - |
ACI-24.060 at Dose B in Study Part 2 | Phase 2 | Amyloid Plaque | - | - |
ACI-24.060 at Dose C in Study Part 2 | Phase 2 | Amyloid Plaque | - | - |
Frequently asked questions
What is in AC Immune SA's drug pipeline?→
CatalystAlert tracks 14 drug candidates in AC Immune SA's (ACIU) pipeline across Phase 2. Its lead program is ACI-24.060 at Dose A (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is AC Immune SA's next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for AC Immune SA (ACIU) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track ACIU biotech catalysts?→
Add ACIU to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow AC Immune SA's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.